Media Thread, page-11224

  1. 134 Posts.
    lightbulb Created with Sketch. 40
    Yeah I’m not sure of the distinction between the different classifications - it does sound like there is overlap. Fast track allows more interaction, think priority review is for a yes/no for approval more quickly is my quick reading of it - someone else can add more nuance if they’d like to.

    the point I was making is I don’t think Imugene will get a voucher - it’s for tropical, rare paediatric, and medical countermeasures only, other things for cancer I guess, like accelerated approval etc?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
37.0¢
Change
0.000(0.00%)
Mkt cap ! $81.29M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 1170 38.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.5¢ 3000 1
View Market Depth
Last trade - 09.46am 18/07/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.